Meghmani Organics Q1 FY27: Lower volumes, stronger margins

Meghmani Organics Limited reported a mixed start to FY27. Q1 FY27 standalone revenue from operations fell 12% year on year to INR 522.9 crore, reflecting softer demand across export and domestic markets. But profitability improved sharply. EBITDA increased 16% year on year to INR 93.7 crore, and PAT rose 42% to INR 57.6 crore. EBITDA margin expanded to 17.9%.

Management attributed the margin improvement to better product mix, disciplined pricing, and operational efficiencies. The company also acknowledged that demand remained subdued across both key standalone segments, which impacted capacity utilisation and overall volumes.

Segment performance: Crop Protection resilient, Pigments recover on margins

In Q1 FY27, Crop Protection contributed about 75% of standalone revenue. Segment revenue stood at INR 391.6 crore, with EBITDA of INR 77.8 crore and EBITDA margin of 19.9%. Production was 8,880 MT, down 17% year on year, and utilisation fell to 63%.

Pigments contributed the remaining 25% of standalone revenue. Segment revenue was INR 131.3 crore, while EBITDA improved to INR 15.9 crore with a 12.1% EBITDA margin. Production was 3,233 MT, down 14% year on year, with utilisation at 39%.

In the earnings call, management indicated that pigment utilisation may remain around current levels, citing demand pressure and industry overcapacity. The focus, according to management, is to protect profitability rather than push volume-driven growth. Management also explained that margin improvement in pigments was driven by better realisations and operational efficiency measures.

Strategy: registrations, selective utilisation, and nano fertilizers

A key strategic pillar remains Crop Protection, where the company continues to invest in registrations and new product development. The investor presentation highlights an expanding registrations base, reaching 893 total registrations in FY26 (450 export registrations and 443 CIB registrations in India). On the call, management reiterated confidence in double digit revenue growth for Crop Protection over the next two to three years, while aiming to maintain profitability around the industry average range of 15% to 17% EBITDA margin.

The investor presentation also highlights the Dahej Multi Purpose Plant with 5,000 MTPA installed capacity, positioned to manufacture high value new-age insecticides. The company listed recently introduced products including flubendamide, cyfluthrin, beta cyfluthrin, spiromesifen, pymetrozine, lambda cyhalothrin and ethiprole. The stated rationale includes building a sustainable supply base to serve global customers and benefit from the China Plus One strategy.

Crop Nutrition continues to be built as a growth lever through Meghmani Crop Nutrition Limited. In the concall, management stated that the segment delivered a positive contribution to revenue and profitability in Q1 FY27 and highlighted expansion of its nano fertilizer basket. Beyond Nano Urea, the company has introduced Nano DAP, Nano NPK and Nano Zinc. Management also stated that nano fertilizers could contribute a couple of INR 100 crores of revenue over the next two to three years, as approvals and market development progress.

TiO2 remains suspended; finance costs trend lower

Titanium Dioxide operations under Kilburn Chemicals Limited remained suspended. Management said the business is commercially unviable due to elevated raw material costs and weaker price realisation following the withdrawal of anti dumping duty. In the concall, management stated KCL recorded negative EBITDA of nearly INR 3 crore in Q1 FY27.

Finance costs were a bright spot. Standalone finance cost declined 62% year on year to INR 9.1 crore in Q1 FY27. The CFO attributed this to lower foreign currency volatility and MTM impact, along with a shift towards INR borrowing at lower rates and ongoing debt reduction. Management also stated it is not planning heavy capex for the next one to two years and intends to continue reducing debt as earnings improve.

Takeaways

Meghmani Organics entered FY27 in a soft demand environment, with lower utilisation across Crop Protection and Pigments. Yet the quarter showed clear improvement in margin delivery, supported by product mix choices and operational actions. The near-term outlook remains sensitive to macro conditions, but management continues to emphasize medium-term growth in Crop Protection through registrations and high value products, and in Crop Nutrition through an expanding nano fertilizer portfolio. The unresolved overhang is TiO2, where operations remain suspended and the timing of any meaningful recovery is uncertain.